Sale!

Immunophenotyping by Flow Cytometry Leukemia Lymphoma Diagnostic Panel for Chronic Lymphoproliferative Disorders T & B Cell Test

Original price was: $700.Current price is: $500.

-29%

The Immunophenotyping by Flow Cytometry Leukemia Lymphoma Diagnostic Panel is a sophisticated diagnostic test designed to identify and characterize chronic lymphoproliferative disorders affecting T and B cells. This advanced flow cytometry analysis provides crucial information for diagnosing various types of leukemia and lymphoma by examining specific cell surface markers and intracellular proteins. The test helps distinguish between different subtypes of lymphoid malignancies, enabling precise treatment planning and monitoring. Patients experiencing unexplained lymph node enlargement, persistent fatigue, night sweats, or abnormal blood counts should consider this comprehensive diagnostic evaluation. At just $500 USD, this test offers rapid same-day results with expert interpretation by specialized hematologists and oncologists, providing essential diagnostic clarity for optimal patient care.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Immunophenotyping by Flow Cytometry Leukemia Lymphoma Diagnostic Panel for Chronic Lymphoproliferative Disorders T & B Cell Test

Comprehensive Diagnostic Testing for Blood Cancers

The Immunophenotyping by Flow Cytometry Leukemia Lymphoma Diagnostic Panel represents a cutting-edge approach to diagnosing and characterizing chronic lymphoproliferative disorders. This sophisticated diagnostic tool utilizes advanced flow cytometry technology to analyze the unique protein markers present on the surface and inside of lymphocytes, providing critical information for accurate diagnosis and treatment planning of various leukemia and lymphoma subtypes.

What This Advanced Test Measures and Detects

This comprehensive diagnostic panel examines multiple cellular characteristics to identify abnormal lymphocyte populations:

  • Surface antigen expression patterns on T and B lymphocytes
  • Intracellular protein markers for cell lineage determination
  • Clonality assessment for malignant cell identification
  • Cell maturation patterns and differentiation stages
  • Abnormal immunophenotypic profiles indicative of specific lymphoma subtypes
  • Minimal residual disease detection capabilities

Who Should Consider This Diagnostic Test

This specialized testing is recommended for individuals presenting with symptoms or clinical findings suggestive of lymphoproliferative disorders:

  • Unexplained persistent lymph node enlargement
  • Unexplained fever, night sweats, or weight loss
  • Abnormal complete blood count results showing lymphocytosis
  • Suspected leukemia or lymphoma based on clinical presentation
  • Patients with known hematological malignancies requiring disease monitoring
  • Individuals with family history of lymphoid cancers
  • Patients with autoimmune conditions developing secondary lymphoproliferative disorders

Significant Benefits of Advanced Immunophenotyping

Choosing this comprehensive diagnostic approach offers multiple advantages for patient care:

  • Precise diagnosis and classification of lymphoid malignancies
  • Early detection of minimal residual disease following treatment
  • Guidance for targeted therapy selection based on specific cell markers
  • Monitoring treatment response and disease progression
  • Distinction between reactive and malignant lymphoid processes
  • Comprehensive assessment of both T and B cell lineages
  • Rapid same-day results for timely clinical decision-making

Understanding Your Diagnostic Results

Your test results will provide detailed information about lymphocyte populations:

  • Normal Results: Indicate no evidence of abnormal lymphocyte populations or clonal expansion
  • Abnormal Patterns: May suggest specific lymphoma or leukemia subtypes based on marker expression
  • Clonality Assessment: Determines whether lymphocyte populations are monoclonal (malignant) or polyclonal (reactive)
  • Lineage Assignment: Identifies whether abnormal cells originate from T or B lymphocyte lineages
  • Maturation Stage: Provides information about the developmental stage of abnormal cells

All results are interpreted by board-certified hematologists and oncologists who provide comprehensive clinical correlation and recommendations.

Test Pricing and Availability

Test Description Price (USD)
Immunophenotyping by Flow Cytometry Leukemia Lymphoma Diagnostic Panel for Chronic Lymphoproliferative Disorders T & B Cell Test – Discount Price $500
Immunophenotyping by Flow Cytometry Leukemia Lymphoma Diagnostic Panel for Chronic Lymphoproliferative Disorders T & B Cell Test – Regular Price $700

Nationwide Testing Availability

We provide comprehensive diagnostic services across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee.

Take Action for Your Health Today

Don’t wait to get the answers you need for proper diagnosis and treatment. Our specialized team of hematologists and oncologists is ready to provide you with comprehensive diagnostic evaluation and expert interpretation. With same-day results and convenient locations nationwide, getting the clarity you need has never been easier.

Book your Immunophenotyping by Flow Cytometry Leukemia Lymphoma Diagnostic Panel today by calling our dedicated healthcare line at +1(267) 388-9828 or schedule your appointment online. Take the first step toward accurate diagnosis and effective treatment planning.